Federal Circuit refuses to rehear Athena dispute; judges call for reform
04-07-2019
Athena asks for rehearing on invalidated neurological disorder patent
09-04-2019
Amerigen loses patent case against UCB at Federal Circuit
14-01-2019
man_at_mouse / iStockphoto.com
In a victory for Mayo Collaborative Services, a US Court has ruled that four claims in a patent, of which Athena Diagnostics is the exclusive licensee, are invalid.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Mayo Clinic Laboratories, Athena Diagnostics, patent dispute, US Court of Appeals for the Federal Circuit, US District Court for the District of Massachus
